Perhaps local export of EBER1 from the EBV-infected cancer cells is sufficient to bind RPL22 in adjacent cytotoxic αβ T cells that are present in the lymphocytic infiltrate and consequently prevent survival or function of these T cells, contributing to immune evasion by the cancer. Here, RPL22 is linked to cancer.